0001666071-23-000138.txt : 20231003
0001666071-23-000138.hdr.sgml : 20231003
20231003182710
ACCESSION NUMBER: 0001666071-23-000138
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231001
FILED AS OF DATE: 20231003
DATE AS OF CHANGE: 20231003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Temsamani Karim Saad
CENTRAL INDEX KEY: 0001944491
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 231305852
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wk-form4_1696372021.xml
FORM 4
X0508
4
2023-10-01
0
0001666071
Cardlytics, Inc.
CDLX
0001944491
Temsamani Karim Saad
675 PONCE DE LEON AVE. NE
SUITE 6000
ATLANTA
GA
30308
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-10-01
4
M
0
50000
A
243768
D
Common Stock
2023-10-02
4
S
0
15463
13.55
D
228305
D
Common Stock
2023-10-02
4
S
0
8299
14.92
D
220006
D
Common Stock
2023-10-02
4
S
0
4708
15.70
D
215298
D
Common Stock
2023-10-02
4
S
0
106
16.35
D
215192
D
Restricted Stock Units
2023-10-01
4
M
0
50000
0
D
Common Stock
50000
100000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.21 to $14.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.27 to $15.265, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.275 to $16.23, inclusive.
This RSU award was originally for 200,000 shares. 25% of the RSU award vested on each of July 1, 2023 and October 1, 2023. An additional 25% of the RSU award shall vest on each of January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date.
/s/ Jason Minio, Attorney-in-Fact
2023-10-03